Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Xanthotoxin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cyclization method for Xanthotoxol and derivatives disclosed in CN102134247A. Offers high yield, reduced steps, and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent CN116554192A details high-purity 8-methoxy psoralen synthesis offering significant supply chain and cost advantages for global pharmaceutical manufacturers.